Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Board Meeting Date

Kwality Pharmaceuticals will hold a board meeting on November 12, 2026. The board will consider and approve unaudited financial results for the quarter and half-year ended September 2026.

Kwality Pharmaceuticals Business Update

Kwality Pharmaceuticals secured EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities. This expands its EU-approved manufacturing footprint and positions it for global licensing opportunities.

Kwality Pharmaceuticals Other Announcement

Kwality Pharmaceuticals Ltd filed its shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.

Kwality Pharmaceuticals Capacity Expansion

Kwality Pharmaceuticals acquired 4 acres adjacent to its Amritsar plant to build a fully automated facility with 10+ production lines. Completion is targeted by Q4 FY2028 with full operations by Q2 FY2029.

Execution

Completion by Q4 FY2028; full operations by Q2 FY2029

manufacturing production lines (injectable + oral solid + ophthalmic)

10 production lines